Literature DB >> 6954973

Treatment of refractory acute leukaemia with high dose cytosine arabinoside.

R Willemze, F E Zwaan, J J Keuning, G Colpin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6954973     DOI： 10.1111/j.1365-2141.1982.tb02808.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

2.  High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma.

Authors:  A Rohatiner; M L Slevin; H S Dhaliwal; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia.

Authors:  E R Grümayer; W Schmidmeier; S Panzer; H Gadner
Journal:  Blut       Date:  1986-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.